Privia Health Reports Officer/Director Changes, Comp Arrangements

Ticker: PRVA · Form: 8-K · Filed: 2024-01-29T00:00:00.000Z

Sentiment: neutral

Topics: executive-changes, compensation, corporate-governance

TL;DR

**Privia Health just reported executive changes and new pay deals, watch for strategic shifts.**

AI Summary

Privia Health Group, Inc. filed an 8-K on January 29, 2024, reporting an event on January 25, 2024, related to changes in directors or officers and their compensation arrangements. This filing indicates potential shifts in leadership or executive incentives, which could impact the company's strategic direction and financial performance. Investors should pay attention to the specifics of these changes as they can signal confidence (or lack thereof) in the company's future and influence stock valuation.

Why It Matters

Changes in executive leadership and compensation can significantly influence a company's strategy, operational efficiency, and ultimately, its stock performance. Investors need to understand who is leading the company and how they are incentivized.

Risk Assessment

Risk Level: medium — Changes in leadership can introduce uncertainty, but also opportunities for new strategic direction, making the risk level moderate.

Analyst Insight

Investors should monitor Privia Health Group, Inc.'s future filings and press releases for specific details on the executive changes and compensation arrangements mentioned in this 8-K, as these specifics will clarify the potential impact on the company's strategy and financial outlook.

Key Numbers

2024-01-25 — Date of Earliest Event Reported (Indicates when the reported changes in officers/directors and compensation arrangements occurred.)
001-40365 — Commission File Number (Unique identifier for Privia Health Group, Inc. with the SEC.)

Key Players & Entities

Privia Health Group, Inc. (company) — the registrant filing the 8-K
January 25, 2024 (date) — date of the earliest event reported
January 29, 2024 (date) — date the 8-K was filed
001-40365 (other) — Commission File No.
PRVA (other) — Trading Symbol for Common Stock
$0.01 (dollar_amount) — par value per share of Common Stock

Forward-Looking Statements

Privia Health Group, Inc. will provide more detailed information regarding the specific officers or directors affected and their new compensatory arrangements in subsequent filings or disclosures. (Privia Health Group, Inc.) — medium confidence, target: 2024-03-31

FAQ

What specific items were reported in this 8-K filing by Privia Health Group, Inc.?

The 8-K filing by Privia Health Group, Inc. reported information under 'ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers', 'ITEM INFORMATION: Regulation FD Disclosure', and 'ITEM INFORMATION: Financial Statements and Exhibits'.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing occurred on January 25, 2024, as stated in the 'Date of Report (Date of earliest event reported): January 25, 2024'.

What is the trading symbol and par value of Privia Health Group, Inc.'s Common Stock?

The trading symbol for Privia Health Group, Inc.'s Common Stock is PRVA, and its par value is $0.01 per share, as indicated under 'Securities registered pursuant to Section 12(b) of the Act: Title of each class Common Stock, $0.01 par value per share Trading Symbol(s) PRVA'.

Where is Privia Health Group, Inc.'s principal executive office located?

Privia Health Group, Inc.'s principal executive office is located at 950 N. Glebe Rd., Suite 700, Arlington, Virginia 22203, according to the filing's 'Address of Principal Executive Offices'.

What is the purpose of an 8-K filing for investors?

An 8-K filing, like this one from Privia Health Group, Inc., is used to announce major events that shareholders should know about, such as changes in leadership or compensation, which can significantly impact the company's future performance and stock value.

From the Filing

0001759655-24-000011.txt : 20240129 0001759655-24-000011.hdr.sgml : 20240129 20240129085242 ACCESSION NUMBER: 0001759655-24-000011 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20240125 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240129 DATE AS OF CHANGE: 20240129 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Privia Health Group, Inc. CENTRAL INDEX KEY: 0001759655 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40365 FILM NUMBER: 24570575 BUSINESS ADDRESS: STREET 1: 950 N. GLEBE RD., SUITE 700 CITY: ARLINGTON STATE: VA ZIP: 22203 BUSINESS PHONE: 571-366-8850 MAIL ADDRESS: STREET 1: 950 N. GLEBE RD., SUITE 700 CITY: ARLINGTON STATE: VA ZIP: 22203 FORMER COMPANY: FORMER CONFORMED NAME: PH Group Parent Corp. DATE OF NAME CHANGE: 20181120 8-K 1 prva-20240125.htm 8-K prva-20240125 0001759655 FALSE 0001759655 2024-01-25 2024-01-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ FORM 8-K _______________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 25, 2024 _________________________ Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) _________________________ Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organization) (Commission File No.) (I.R.S. Employer Identification No.) 950 N. Glebe Rd., Suite 700 Arlington, Virginia 22203 (Address of Principal Executive Offices) (Zip Code) ( 571 ) 366-8850 Registrant's telephone number, including area code Not Applicable (Former name, former address and former fiscal year, if changed since last report) Check the appropriate box below if the form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2 (b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value per share PRVA The Nasdaq Global Select Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On January 25, 2024 the Board of Directors (the “Board”) of Privia Health Group, Inc. (the “Company”) approved a transition letter agreement (the “Transition Agreement”) between the Company and Thomas Bartrum, the current Executive Vice President & General Counsel. Un